In a 2015 commencement address at George Washington University, Apple CEO Tim Cook told graduates that their values should serve as their “North Star.” Work, he said, takes on new meaning when people feel pointed in the right direction. Otherwise, “it’s just a job, and life is too short for that.”
For generations, American medicine was built on a similar idea: that being a doctor was not just a job, but a calling rooted in service.
Not long ago, most physicians practiced in small, independent offices. They decided which patients to see, how long to spend with each and how care would be delivered. Their identity and purpose were clear. They were doctors, trained through years of sacrifice to keep people healthy, relieve suffering and save lives.
That era of medicine has been replaced by one in which physicians increasingly struggle to balance mission and financial stability. In that tradeoff, most have chosen stability.
All but 38% of physicians have left or sold their practices. The majority now work for hospital systems, private equity firms or insurers in return for greater negotiating clout, administrative support and economic security. Among those who remain independent, a growing number have embraced concierge medicine, a model in which patients pay an annual fee (typically several thousand dollars, with some practices charging $20,000 or more) for enhanced access and personalized care. For physicians, the appeal is clear: fewer patients, more time per visit and higher income.
These choices are rational. For most doctors, they feel like the only way to protect their families, preserve their careers and survive inside an increasingly unforgiving system.
CFOs often say there can be no mission without margin. They are right. Financial stability matters in medicine, as it does in every profession. But the reverse is also true: without mission, medicine risks becoming, in Tim Cook’s words, “just a job.”
That is the danger many physicians may not fully recognize when they trade independence, access or autonomy for financial security. The gain is visible immediately. The loss only becomes clear only over time.
Cook’s recent retirement, and the debate over his legacy, offers a powerful case study in what happens when institutional optimization and personal values collide. His story helps illuminate the choices now facing medicine, and the consequences that follow when mission and margin move in opposite directions.
The Tradeoffs Behind Tim Cook’s Success
By almost every measurable business standard, Tim Cook’s tenure as Apple CEO was a historic success. After succeeding Steve Jobs in 2011, he transformed Apple from a beloved consumer tech company into one of the most valuable corporations in history.
In the years that followed, Apple’s market capitalization rose from roughly $350 billion to nearly $4 trillion. Annual profits more than quadrupled. Products like the Apple Watch and AirPods became major revenue drivers, while Apple’s services business fundamentally reshaped the company’s economics.
Through this financial lens, Cook’s leadership received near-universal praise. But those metrics do not capture the personal compromises he made to achieve that level of performance or the price those choices likely carried. Cook’s public persona rested on discipline, restraint and values-based leadership. He framed privacy as a “fundamental human right” and argued that technology should be built around trust, accessibility and respect for users.
But his actions told a different story. And when the values people expound and the actions that they take deviate from one another, psychologists describe the result as cognitive dissonance: an uncomfortable internal conflict.
News articles and podcast retrospectives have questioned Cook’s $1 million donation to Trump’s 2025 inauguration, the custom glass plaque mounted on a 24-karat gold base he gave the president and his attendance at a private White House screening of Melania. There is nothing intrinsically wrong with cultivating a president’s favor, but it is hard to reconcile these actions with Cook’s public image and stated values.
From a financial and shareholder-value perspective, the strategy appears to have worked. As Trump ratcheted up tariffs on imports from India in 2025, the president exempted smartphones and semiconductors, sparing Apple significant costs.
A similar conflict between values and margin appears in Cook’s dealings with China. Over 15 years, he built one of the most sophisticated global supply chains in history, giving Apple a massive competitive advantage. But doing so tied the company to a government known for censorship, human rights violations and a manufacturing system long criticized for its working conditions. To critics, Cook’s willingness to accept those tradeoffs once again ran contrary to his public commitments to privacy, dignity and human-centered technology.
The leaders of publicly traded companies may view such compromises as essential to business success. But what happens when financial optimization pulls clinicians away from their “North Star”?
How Financial Incentives Reshaped Medical Practice
In 1970, economist Milton Friedman famously argued that the social responsibility of business was to increase profits for shareholders, so long as companies followed the rules of the game. That idea helped define modern American capitalism and the expectations placed on corporate executives.
But medicine is not just another business. Here, the question is what happens to mission-driven doctors when they pursue a finance-first approach, either for their own financial benefit or for the benefit of the hospital, private equity firm or insurer that owns their practice?
Most physicians will never again have the combined autonomy and financial security of previous generations. Industry consolidation has shifted negotiating power away from doctors and toward large hospital systems, insurer-owned medical groups and private equity-backed organizations. These entities have the scale to negotiate higher reimbursement rates, spread administrative costs and operate more efficiently than smaller, independent practices.
Moreover, physician reimbursements from Medicare and Medicaid aren’t keeping pace with inflation. Prior authorization requirements alone force physicians and their staff to spend an average of 13 hours each week navigating approvals, time that could otherwise be spent caring for patients. Furthermore, these financial pressures come on top of the rising cost of staffing, technology, compliance and malpractice coverage.
It is no wonder more than 60% of U.S. physicians are now employed by hospitals, health systems or corporate entities, a dramatic shift from about 40% just a decade ago. Physicians know that joining one of these hospital systems can increase reimbursement rates by 8% to 10% on average, creating a level of financial stability they could not achieve on their own.
Private equity investment has accelerated as well, with roughly 8% of physicians now practicing in PE-backed groups, nearly doubling since 2022. Doctors hope that by selling their practice to private equity, they will receive operational support and long-term financial gain.
In parallel, concierge and direct primary care practices have expanded greatly in recent years. According to Health Affairs, the number of physicians practicing in these models more than doubled between 2018 and 2023, with continued growth since.
What is rarely discussed outside policy circles are the consequences of these financial choices on patient care.
Join a hospital system, and physicians may earn more, but healthcare becomes more unaffordable for both patients and small business owners. Sell a practice to private equity, and studies show the transition is followed by staffing reductions, higher utilization and declines in multiple measures of care quality. Become a concierge doctor, and a physician may earn more caring for 500 patients than previously earned with a panel of 2,000. But that decision also means telling the other 1,500 patients who cannot afford a multi-thousand-dollar annual fee to find another doctor.
